David Santos

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

RIGL

Current role

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2024	Rigel Pharmaceuticals Inc (RIGL)	Executive Vice President and Chief Commercial Officer	$496,080	—	$265,430	$307,500	$277,805	$35,648	$1,382,463
2023	Rigel Pharmaceuticals Inc (RIGL)	Executive Vice President and Chief Commercial Officer	$477,000	—	$149,600	$455,008	$230,153	$30,030	$1,341,791
2022	Rigel Pharmaceuticals Inc (RIGL)	Executive Vice President and Chief Commercial Officer	$450,000	—	$121,000	$321,780	$204,525	$27,110	$1,124,415
2020	Rigel Pharmaceuticals Inc (RIGL)	Executive Vice President and Chief Commercial Officer	$163,726	—	—	$155,625	$819,854	$51,397	$1,190,602
2019	Rigel Pharmaceuticals Inc (RIGL)	Executive Vice President and Chief Commercial Officer	—	—	—	—	—	—	—
2018	Rigel Pharmaceuticals Inc (RIGL)	Executive Vice President and Chief Commercial Officer	—	—	—	—	—	—	—

No earnings-call appearances or filed executive changes recorded yet.